These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
232 related articles for article (PubMed ID: 34687970)
1. Risk Prediction and Comparative Efficacy of Anti-TNF vs Thiopurines, for Preventing Postoperative Recurrence in Crohn's Disease: A Pooled Analysis of 6 Trials. Beelen EMJ; Nieboer D; Arkenbosch JHC; Regueiro MD; Satsangi J; Ardizzone S; López-Sanromán A; Savarino E; Armuzzi A; Janneke van der Woude C; de Vries AC Clin Gastroenterol Hepatol; 2022 Dec; 20(12):2741-2752.e6. PubMed ID: 34687970 [TBL] [Abstract][Full Text] [Related]
2. Comparative Efficacy of Anti-TNF Therapies For The Prevention of Postoperative Recurrence of Crohn's Disease: A Systematic Review and Network Meta-Analysis of Prospective Trials. Bakouny Z; Yared F; El Rassy E; Jabbour R; Hallit R; Khoury N; Honein K; Bou Jaoude J J Clin Gastroenterol; 2019 Jul; 53(6):409-417. PubMed ID: 29517709 [TBL] [Abstract][Full Text] [Related]
3. Efficacy of thiopurines and adalimumab in preventing Crohn's disease recurrence in high-risk patients - a POCER study analysis. De Cruz P; Kamm MA; Hamilton AL; Ritchie KJ; Krejany EO; Gorelik A; Liew D; Prideaux L; Lawrance IC; Andrews JM; Bampton PA; Jakobovits S; Florin TH; Gibson PR; Debinski H; Gearry RB; Macrae FA; Leong RW; Kronborg I; Radford-Smith G; Selby W; Johnston MJ; Woods R; Elliott PR; Bell SJ; Brown SJ; Connell WR; Desmond PV Aliment Pharmacol Ther; 2015 Oct; 42(7):867-79. PubMed ID: 26314275 [TBL] [Abstract][Full Text] [Related]
4. Azathioprine and 6-mercaptopurine for maintenance of surgically-induced remission in Crohn's disease. Gordon M; Taylor K; Akobeng AK; Thomas AG Cochrane Database Syst Rev; 2014 Aug; 2014(8):CD010233. PubMed ID: 25081347 [TBL] [Abstract][Full Text] [Related]
5. Thiopurines are superior to mesalamine for preventing postoperative recurrence in patients with Crohn's disease and two or more risk factors. Huang ZC; Yang QF; Tang J; Li M; Chao K; Gao X J Dig Dis; 2021 Oct; 22(10):590-596. PubMed ID: 34453408 [TBL] [Abstract][Full Text] [Related]
6. Systematic review: The use of thiopurines or anti-TNF in post-operative Crohn's disease maintenance--progress and prospects. Jones GR; Kennedy NA; Lees CW; Arnott ID; Satsangi J Aliment Pharmacol Ther; 2014 Jun; 39(11):1253-65. PubMed ID: 24738574 [TBL] [Abstract][Full Text] [Related]
7. Antitumor Necrosis Factor Agents to Treat Endoscopic Postoperative Recurrence of Crohn's Disease: A Nationwide Study With Propensity-Matched Score Analysis. Cañete F; Mañosa M; Pérez-Martínez I; Barreiro-de Acosta M; González-Sueyro RC; Nos P; Iglesias-Flores E; Gutiérrez A; Bujanda L; Gordillo J; Ríos León R; Casanova MJ; Villoria A; Rodríguez-Lago I; López Serrano P; García-Herola A; Ramírez-de la Piscina P; Navarro-Llavat M; Taxonera C; Barrio J; Ramos L; Navarro P; Benítez-Leiva O; Calafat M; Domènech E; Clin Transl Gastroenterol; 2020 Aug; 11(8):e00218. PubMed ID: 32955190 [TBL] [Abstract][Full Text] [Related]
8. Adalimumab in prevention of postoperative recurrence of Crohn's disease in high-risk patients. Aguas M; Bastida G; Cerrillo E; Beltrán B; Iborra M; Sánchez-Montes C; Muñoz F; Barrio J; Riestra S; Nos P World J Gastroenterol; 2012 Aug; 18(32):4391-8. PubMed ID: 22969204 [TBL] [Abstract][Full Text] [Related]
9. Azathioprine and 6-mercaptopurine for maintenance of surgically-induced remission in Crohn's disease. Gjuladin-Hellon T; Iheozor-Ejiofor Z; Gordon M; Akobeng AK Cochrane Database Syst Rev; 2019 Aug; 8(8):CD010233. PubMed ID: 31425621 [TBL] [Abstract][Full Text] [Related]
11. Mercaptopurine versus placebo to prevent recurrence of Crohn's disease after surgical resection (TOPPIC): a multicentre, double-blind, randomised controlled trial. Mowat C; Arnott I; Cahill A; Smith M; Ahmad T; Subramanian S; Travis S; Morris J; Hamlin J; Dhar A; Nwokolo C; Edwards C; Creed T; Bloom S; Yousif M; Thomas L; Campbell S; Lewis SJ; Sebastian S; Sen S; Lal S; Hawkey C; Murray C; Cummings F; Goh J; Lindsay JO; Arebi N; Potts L; McKinley AJ; Thomson JM; Todd JA; Collie M; Dunlop MG; Mowat A; Gaya DR; Winter J; Naismith GD; Ennis H; Keerie C; Lewis S; Prescott RJ; Kennedy NA; Satsangi J; Lancet Gastroenterol Hepatol; 2016 Dec; 1(4):273-282. PubMed ID: 28404197 [TBL] [Abstract][Full Text] [Related]
12. Previous Exposure to Multiple Anti-TNF Is Associated with Decreased Efficiency in Preventing Postoperative Crohn's Disease Recurrence. Collins M; Sarter H; Gower-Rousseau C; Koriche D; Libier L; Nachury M; Cortot A; Zerbib P; Blanc P; Desreumaux P; Colombel JF; Peyrin-Biroulet L; Pineton de Chambrun G J Crohns Colitis; 2017 Mar; 11(3):281-288. PubMed ID: 27578800 [TBL] [Abstract][Full Text] [Related]
13. Infliximab Reduces Endoscopic, but Not Clinical, Recurrence of Crohn's Disease After Ileocolonic Resection. Regueiro M; Feagan BG; Zou B; Johanns J; Blank MA; Chevrier M; Plevy S; Popp J; Cornillie FJ; Lukas M; Danese S; Gionchetti P; Hanauer SB; Reinisch W; Sandborn WJ; Sorrentino D; Rutgeerts P; Gastroenterology; 2016 Jun; 150(7):1568-1578. PubMed ID: 26946343 [TBL] [Abstract][Full Text] [Related]
14. Prevention and treatment of postoperative Crohn's disease recurrence with anti-TNF therapy: a meta-analysis of controlled trials. Carla-Moreau A; Paul S; Roblin X; Genin C; Peyrin-Biroulet L Dig Liver Dis; 2015 Mar; 47(3):191-6. PubMed ID: 25488057 [TBL] [Abstract][Full Text] [Related]
15. Adalimumab or Infliximab for the Prevention of Early Postoperative Recurrence of Crohn Disease: Results From the ENEIDA Registry. Cañete F; Mañosa M; Casanova MJ; González-Sueyro RC; Barrio J; Bermejo F; Nos P; Iglesias-Flores E; García-Planella E; Pérez-Calle JL; Vicente R; Vera M; Ramos L; Rivero M; De Francisco R; Montserrat A; Benítez O; Navarro P; Taxonera C; Hinojosa E; Márquez-Mosquera L; Navarro-Llavat M; Ramírez-de la Piscina P; Gomollón F; Rodríguez-Alonso L; Núñez-Alonso A; Fernández-Salazar L; Almela P; Ríos León R; De Castro L; Gisbert JP; Ricart E; Cabré E; Domènech E; Inflamm Bowel Dis; 2019 Oct; 25(11):1862-1870. PubMed ID: 31006801 [TBL] [Abstract][Full Text] [Related]
16. Colonoscopy-guided therapy for the prevention of post-operative recurrence of Crohn's disease. Candia R; Bravo-Soto GA; Monrroy H; Hernandez C; Nguyen GC Cochrane Database Syst Rev; 2020 Aug; 8(8):CD012328. PubMed ID: 32746500 [TBL] [Abstract][Full Text] [Related]
17. Effectiveness of Mesalazine, Thiopurines and Tumour Necrosis Factor Antagonists in Preventing Post-Operative Crohn's Disease Recurrence in a Real-Life Setting. Allocca M; Landi R; Bonovas S; Fiorino G; Papa A; Spinelli A; Furfaro F; Peyrin-Biroulet L; Armuzzi A; Danese S Digestion; 2017; 96(3):166-172. PubMed ID: 28903094 [TBL] [Abstract][Full Text] [Related]
18. Anti-TNF Agents and New Biological Agents (Vedolizumab and Ustekinumab) in the Prevention and Treatment of Postoperative Recurrence After Surgery in Crohn's Disease. Gisbert JP; Chaparro M Drugs; 2023 Sep; 83(13):1179-1205. PubMed ID: 37505446 [TBL] [Abstract][Full Text] [Related]
19. Ustekinumab is more effective than azathioprine to prevent endoscopic postoperative recurrence in Crohn's disease. Buisson A; Nancey S; Manlay L; Rubin DT; Hebuterne X; Pariente B; Fumery M; Laharie D; Roblin X; Bommelaer G; Pereira B; Peyrin-Biroulet L; Vuitton L; United European Gastroenterol J; 2021 Jun; 9(5):552-560. PubMed ID: 33951350 [TBL] [Abstract][Full Text] [Related]
20. Systematic Review and Network Meta-Analysis of Medical Therapies to Prevent Recurrence of Post-Operative Crohn's Disease. Burr NE; Hall B; Hamlin PJ; Selinger CP; Ford AC; O'Connor A J Crohns Colitis; 2019 May; 13(6):693-701. PubMed ID: 30561586 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]